Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Immunitas Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Immunitas Therapeutics

Immunitas Therapeutics

Series B

US-based Immunitas advances immuno-oncology therapeutics through an integrated genomics platform.

HQ
Waltham, MA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Immunitas Therapeutics, founded in Waltham, United States, is dedicated to advancing immuno-oncology therapeutics. The company's core mission is to discover and develop novel, differentiated treatments for cancer patients. Utilizing a highly integrated single-cell genomics platform, Immunitas rapidly identifies and validates targets while simultaneously discovering antibodies. Their market focus is on precision immunotherapy, leveraging deep expertise in single-cell genomics and machine learning to understand immune cell populations.

Notable figures associated with Immunitas include leading experts in genomics and oncology. The company has attracted significant investment from prominent venture capital firms in the biotech sector. Key achievements include the successful advancement of multiple therapeutic programs to clinical stages. Immunitas' impact lies in its innovative approach to cancer treatment, promising more effective and personalized therapies for patients.

Immunitas Therapeutics - Similar Companies

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

immuneonc.com

Immunai logo

Immunai

ImmunoGenesis logo

ImmunoGenesis

immunogenesis.com

INmune Bio logo

INmune Bio

inmunebio.com

ImmunoMet Therapeutics logo

ImmunoMet Therapeutics

immunomet.com

ImmunoMind logo

ImmunoMind

ImmuneID logo

ImmuneID

Immunome logo

Immunome

Imvaq Therapeutics logo

Imvaq Therapeutics

ImmuneXcite logo

ImmuneXcite

Inimmune logo

Inimmune

inimmune.com

ImmuneSensor Therapeutics logo

ImmuneSensor Therapeutics

immunesensor.com

GO Therapeutics logo

GO Therapeutics

gotherapeutics.com

ImmunityBio logo

ImmunityBio

immunitybio.com

Immpact Bio logo

Immpact Bio

immpact-bio.com

Immunitas Therapeutics - Quick Facts

Who are Immunitas Therapeutics' competitors?

Companies similar to Immunitas Therapeutics include Immune-Onc Therapeutics, Immunai, ImmunoGenesis and INmune Bio.

When was Immunitas Therapeutics founded?

Immunitas Therapeutics was founded in 2019.

Where is Immunitas Therapeutics' headquarters located?

Immunitas Therapeutics' headquarters is located in Waltham, MA, US.

When was Immunitas Therapeutics' last funding round?

Immunitas Therapeutics' most recent funding round was for $58M (USD) in August 2021.

How much has Immunitas Therapeutics raised to-date?

As of Aug 18, 2021, Immunitas Therapeutics has raised a total of $97M (USD).

How many employees does Immunitas Therapeutics have?

Immunitas Therapeutics has 33 employees as of Feb 5, 2024.

Immunitas Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Therapeutics
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified